Literature DB >> 241524

Pharmacology of BS 100-141, a centrally acting antihypertensive drug.

K Saameli, G Scholtysik, R Waite.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 241524

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


× No keyword cloud information.
  18 in total

1.  Pharmacology of guanfacine.

Authors:  G Scholtysik
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

2.  Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure.

Authors:  J R Kiechel; D Lavene; M Guerret; E Comoy; M Godin; J P Fillastre
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.

Authors:  A J Bune; J P Chalmers; J R Graham; P R Howe; M J West; L M Wing
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  An ambulatory trial of guanfacine.

Authors:  S Mann; M W Millar Craig; D I Melville; P M Cashman; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

5.  Experiences with guanfacine in a two-year follow-up study.

Authors:  G Titscher
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

6.  Elimination of guanfacine in patients with normal and impaired renal function.

Authors:  W Kirch; H Köhler; W Braun
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

7.  Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.

Authors:  R Lauro; G Reda; L Spallone; A B Anguissola
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

8.  Differences in psychic performance with guanfacine and clonidine in normotensive subjects.

Authors:  J Kugler; R Seus; R Krauskopf; H M Brecht; A Raschig
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

Review 9.  Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-04       Impact factor: 9.546

10.  [3H]-guanfacine: a radioligand that selectively labels high affinity alpha2-adrenoceptor sites in homogenates of rat brain.

Authors:  B Jarrott; W J Louis; R J Summers
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.